Anticytokine therapy in neuropathic pain management.

Anticytokine therapy in neuropathic pain management. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Anticytokine therapy in neuropathic pain management. Abstract Text:

Maria ,Claudia Sommer,Maria ,Claudia Sommer,

Cytokine activation or dysregulation is implied in a variety of painful disease states. Numerous experimental studies provide evidence that proinflammatory cytokines induce or facilitate neuropathic pain. Cytokine levels are rapidly and markedly upregulated in the peripheral nerves, dorsal root ganglia, spinal cord and in particular regions of the brain, after peripheral nerve injuries. Direct receptor-mediated actions on afferent nerve fibers as well as cytokine effects involving further mediators have been reported. Whereas direct application of exogenous proinflammatory cytokines induces pain, blockade of these cytokines or application of anti-inflammatory cytokines reduces pain behavior in most experimental paradigms. Cytokine measurements may identify patients at risk of developing chronic pain associated with their neuropathic conditions, as in the examples of peripheral neuropathies and postherpetic neuralgia. Anticytokine agents currently on the market are effective for the treatment of mostly inflammatory pain conditions, and are starting to be introduced for neuropathic pain states; however, their use is limited by potential life-threatening complications. Owing to the pleiotropy and redundancy of the cytokine system, the successful approach may not be inhibition of one particular cytokine but strategies shifting the balance between pro- and anti-inflammatory cytokines in properly selected patients. Agents that specifically target downstream signaling molecules may provide hope for safer and more specific therapies.

Anticytokine therapy in neuropathic pain management. Publishing Authors By Initials

M ,C Sommer,M ,C Sommer,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Anticytokine therapy in neuropathic pain management. Journal Published:

PUBLICATION TYPE: Review

Journal: Expert review of neurotherapeutics

VOLUME: 7

Page Numbers: 1613-27

Journal Abbreviation:

ISSN: 1744-8360

DAY: 13

MONTH: Nov

YEAR: 2007

Anticytokine therapy in neuropathic pain management. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101129944

Anticytokine therapy in neuropathic pain management. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Anticytokine therapy in neuropathic pain management. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Anticytokine therapy in neuropathic pain management.

AFFILIATION: Department of Neurology, University of Duisburg-Essen, Hufelandstr. 55,45147 Essen, Germany. maria.schaefers@uni-due.de

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Expert Rev Neurother

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Anticytokine therapy in neuropathic pain management Related Publications

• A large-scale validation of dosage analysis by robust dosage-polymerase chain reaction.
• A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin.
• A novel image formation method for ultrasonic strain imaging.
• Analysis of urinary calculi using an infrared microspectroscopic surface reflectance imaging technique.
• Anticytokine therapy in neuropathic pain management.
• Antiinfectives and low-level light: a new chapter in photomedicine.
• Autonomic neurogenesis and apoptosis are alternative fates of progenitor cell communities induced by TGFbeta.
• Candidate gene analyses by scanning or brute force fluorescent sequencing: a comparison of DOVAM-S with gel-based and capillary-based sequencing.
• Classification and management of tracheoesophageal and tracheopharyngeal fistulas after laryngectomy.
• Detection of ultrarare somatic mutation in the human TP53 gene by bidirectional pyrophosphorolysis-activated polymerization allele-specific amplification.
• Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies.
• Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice.
• Evidence for mutation showers.
• Evolution of development in nematodes related to C. elegans.
• FDG-PET and FDG-PET/CT in breast cancer.
• Facial attractiveness modulates early and late event-related brain potentials.
• Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineurs.
• High-resolution myocardial perfusion imaging at 3 T: comparison to 1.5 T in healthy volunteers.
• In vitro comparison of human fibroblasts from intact and ruptured ACL for use in tissue engineering.
• Magnetic resonance-guided high-intensity ultrasound ablation of the prostate.
• Mean-field treatment of polymer chains trapped between surfaces and penetrable interfaces.
• Molecular Structure and Theoretical Studies of (PPh(4))(2)[Bi(10)Cu(10)(SPh)(24)].
• Pristionchus pacificus.
• Random copolymers at a selective interface: Saturation effects.
• The ClpPX protease is required for radioresistance and regulates cell division after gamma-irradiation in Deinococcus radiodurans.
• The Nematode Pristionchus pacificus (Nematoda: Diplogastridae) Is Associated with the Oriental Beetle Exomala orientalis (Coleoptera: Scarabaeidae) in Japan.
• Toward a fluorescent single-strand conformation polymorphism technique that detects all mutations: F-DOVAM-S.
• Treatment of lymphangioma circumscriptum with the intense pulsed light system.
• [Physical training in the treatment of depressive disorders]
• [Stem cells of the enteric nervous system: causal therapy for Hirschsprung's disease?]